相似文献
1
Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.
J Med Chem. 2013 Feb 28;56(4):1782-6. doi: 10.1021/jm4000177. Epub 2013 Feb 19.
2
Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.
Chemistry. 2012 Mar 19;18(12):3675-86. doi: 10.1002/chem.201103344. Epub 2012 Feb 10.
3
Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.
J Med Chem. 2010 Sep 23;53(18):6747-57. doi: 10.1021/jm100592u.
4
Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
J Am Chem Soc. 2012 Dec 5;134(48):19858-68. doi: 10.1021/ja309187m. Epub 2012 Nov 16.
5
Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Chem Commun (Camb). 2010 Nov 28;46(44):8442-4. doi: 10.1039/c0cc03145c. Epub 2010 Oct 1.
6
Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.
Inorg Chem. 2015 Mar 2;54(5):2403-10. doi: 10.1021/ic503035f. Epub 2015 Feb 18.
7
Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Chemistry. 2005 May 6;11(10):3077-86. doi: 10.1002/chem.200401207.
8
Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.
Dalton Trans. 2014 Feb 28;43(8):3162-73. doi: 10.1039/c3dt52958d.
9
Noncovalent binding of some new lipophilic gadolinium DTPA complexes to human serum albumin. A structure-affinity relationship.
Chem Biodivers. 2010 Dec;7(12):2846-55. doi: 10.1002/cbdv.201000194.
10
The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
J Med Chem. 2002 Aug 1;45(16):3465-74. doi: 10.1021/jm0102351.
引用本文的文献
1
Metal-Mediated, Autolytic Amide Bond Cleavage: A Strategy for the Selective, Metal Complexation-Catalyzed, Controlled Release of Metallodrugs.
J Am Chem Soc. 2023 Jul 26;145(29):16261-16270. doi: 10.1021/jacs.3c05492. Epub 2023 Jul 11.
2
Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.
Pharm Res. 2021 Sep;38(9):1497-1518. doi: 10.1007/s11095-021-03093-x. Epub 2021 Aug 31.
3
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Chem Rev. 2019 Jan 23;119(2):957-1057. doi: 10.1021/acs.chemrev.8b00363. Epub 2018 Oct 16.
4
Intramolecular Hydrogen Bonding Restricts Gd-Aqua-Ligand Dynamics.
Angew Chem Int Ed Engl. 2017 May 8;56(20):5603-5606. doi: 10.1002/anie.201702274. Epub 2017 Apr 11.
5
Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.
Inorg Chem. 2015 Mar 2;54(5):2403-10. doi: 10.1021/ic503035f. Epub 2015 Feb 18.
6
Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.
Bioconjug Chem. 2014 Sep 17;25(9):1720-9. doi: 10.1021/bc500309r. Epub 2014 Aug 21.
7
Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.
Inorg Chem. 2014 Jul 7;53(13):6985-94. doi: 10.1021/ic5008928. Epub 2014 Jun 12.
8
B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.
J Biol Inorg Chem. 2014 Jun;19(4-5):715-26. doi: 10.1007/s00775-014-1111-z. Epub 2014 Feb 8.
9
Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imaging.
Inorg Chem. 2013 Dec 16;52(24):14284-93. doi: 10.1021/ic402233g. Epub 2013 Dec 4.
10
Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Biomaterials. 2013 Oct;34(31):7683-93. doi: 10.1016/j.biomaterials.2013.06.057. Epub 2013 Jul 14.
本文引用的文献
1
Enzyme-Activated Gd Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement.
Angew Chem Int Ed Engl. 2001 Aug 3;40(15):2903-2906. doi: 10.1002/1521-3773(20010803)40:15<2903::AID-ANIE2903>3.0.CO;2-N.
2
Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
J Am Chem Soc. 2012 Dec 5;134(48):19858-68. doi: 10.1021/ja309187m. Epub 2012 Nov 16.
3
Structure - relaxivity relationships among targeted MR contrast agents.
Eur J Inorg Chem. 2012 Apr;2012(12):1916-1923. doi: 10.1002/ejic.201101364.
4
Analytical methods for characterizing magnetic resonance probes.
Anal Chem. 2012 Aug 7;84(15):6278-87. doi: 10.1021/ac300527z. Epub 2012 May 23.
5
Synthesis and physicochemical characterization of carbon backbone modified [Gd(TTDA)(H2O)]2- derivatives.
Inorg Chem. 2011 Feb 21;50(4):1275-87. doi: 10.1021/ic101799c. Epub 2011 Jan 19.
6
Advances in metal-based probes for MR molecular imaging applications.
Curr Med Chem. 2010;17(31):3684-700. doi: 10.2174/092986710793213823.
7
Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry.
J Phys Chem B. 2010 Mar 18;114(10):3689-97. doi: 10.1021/jp910961j.
8
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Acc Chem Res. 2009 Jul 21;42(7):851-62. doi: 10.1021/ar800220p.
9
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.
Contrast Media Mol Imaging. 2009 Mar-Apr;4(2):89-100. doi: 10.1002/cmmi.267.
10
Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
Inorg Chem. 2007 Aug 6;46(16):6632-9. doi: 10.1021/ic700686k. Epub 2007 Jul 11.
Zotero 插件